Coronavirus Disease 2019 (COVID-19)– CDC
Approximately 25 announcements/reports/data summaries.
1/7/22 EARLY RELEASE: Risk for Newly Diagnosed Diabetes 30 Days After SARS-CoV-2 Infection Among Persons Aged 18 years — United States, March 1, 2020–June 28, 2021
1/7/22 EARLY RELEASE: Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
1/7/22 Overall US COVID-19 Vaccine Distribution and Administration Update as of Fri, 07 Jan 2022 06:00:00 EST
1/7/22 COVID-19 Vaccine Booster Shot
1/7/22 COVID-19 Vaccines for Moderately to Severely Immunocompromised People
1/7/22 Staffing Resources
1/7/22 Information about the Moderna COVID-19 Vaccine
1/7/22 Different COVID-19 Vaccines
1/7/22 Infection Prevention and Control Assessment Tool for Nursing Homes Preparing for COVID-19
1/7/22 COVID Data Tracker Weekly Review
1/6/22 CDC Media Telebriefing: Update on COVID-19
1/6/22 Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021
1/6/22Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021
1/6/22 Overview of COVID-19 Isolation for K-12 Schools
1/6/22 Overview of COVID-19 Quarantine for K-12 Schools
1/6/22 Responding to COVID-19 Cases in K-12 Schools: Resources for School Administrators
1/6/22 What You Should Know About COVID-19 Testing in Schools
1/6/22 Guidance for COVID-19 Prevention in Kindergarten (K)-12 Schools
1/6/22 Information about the Pfizer-BioNTech COVID-19 Vaccine
1/6/22 Schools and Childcare Programs
1/5/22 CDC Expands Booster Shot Eligibility and Strengthens Recommendations for 12-17 Year Olds